Walgreens Is Ready to Report Fiscal 2Q17 Earnings: What to Expect
WBA ready to post fiscal 2Q17 results
Walgreens Boots Alliance (WBA), based in Deerfield, Illinois, is slated to release its fiscal 2Q17 results on Wednesday, April 5, 2017.
EPS (earnings per share) is projected to rise 3.8% YoY (year-over-year) to $1.36 on total sales of $30.3 billion, a 0.40% rise YoY. In fiscal 1Q17, EPS was $1.10, which was $0.01 better than Wall Street’s estimate.
Walgreens has delivered better-than-consensus earnings forecasts in the last nine consecutive quarters. However, it has missed on revenue estimates in eight of those nine quarters.
Interested in WBA? Don't miss the next report.
Receive e-mail alerts for new research on WBA
Walgreens is currently trading at a one-year earnings multiple of 16.3x. That’s close to the lower end of its 52-week PE (price-to-earnings) ratio of 15.8x–18.8x. In comparison, CVS Health (CVS), AmerisourceBergen (ABC), and McKesson (MCK) are trading at 13.4x, 14.7x, and 12.7x, respectively, to the next 12 months of earnings.
Walgreens is covered by 25 Wall Street analysts. About 76.0% of them have given WBA stock a “buy” recommendation, and 24.0% have recommended a “hold.” There are no “sell” ratings for the stock.
With a market capitalization of $90.2 billion as of March 27, 2017, Walgreens Boots Alliance has a weight of 3.9% in the Consumer Staples Select Sector SPDR ETF (XLP).
What’s this series all about?
This series is a preview of Walgreens Boots Alliance’s (WBA) upcoming fiscal 2Q17 results. We’ll look at the company’s past financial performance and its expected performance for fiscal 2Q17. We’ll also look at the performance of WBA stock and Wall Street’s recommendations.